DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Locke F, Ghobadi A, Jacobson CA. et al.
Long‐term safety and activity of axicabtagene ciloleucel in refractory large B‐cell lymphoma (ZUMA‐1): a single‐arm, multicentre, phase 1–2 trial.
Lancet Oncol 2019;
20: 31-42
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.